81 related articles for article (PubMed ID: 14973547)
1. Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo.
Nagane M; Shimizu S; Mori E; Kataoka S; Shiokawa Y
Neuro Oncol; 2010 Jul; 12(7):687-700. PubMed ID: 20511188
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas.
Shinoura N; Yamamoto N; Yoshida Y; Fujita T; Saito N; Asai A; Kirino T; Hamada H
Jpn J Cancer Res; 2000 Jan; 91(1):41-51. PubMed ID: 10744043
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively.
Weber TG; Osl F; Renner A; Pöschinger T; Galbán S; Rehemtulla A; Scheuer W
Cancer Res; 2014 Apr; 74(7):1913-23. PubMed ID: 24509903
[TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
Roth W; Fontana A; Trepel M; Reed JC; Dichgans J; Weller M
Cancer Immunol Immunother; 1997 Mar; 44(1):55-63. PubMed ID: 9111585
[TBL] [Abstract][Full Text] [Related]
5. Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT.
Zhang Y; Huang S; Leng Y; Chen X; Liu T; Wang H; Wei F; Luo D; Chen G; Wei Z
Onco Targets Ther; 2016; 9():5195-202. PubMed ID: 27621648
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the apoptotic programs in cancer stem-like cells.
Wang YH; Scadden DT
EMBO Rep; 2015 Sep; 16(9):1084-98. PubMed ID: 26253117
[TBL] [Abstract][Full Text] [Related]
7. A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
Rajeshkumar NV; Rasheed ZA; García-García E; López-Ríos F; Fujiwara K; Matsui WH; Hidalgo M
Mol Cancer Ther; 2010 Sep; 9(9):2582-92. PubMed ID: 20660600
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5).
Forero-Torres A; Shah J; Wood T; Posey J; Carlisle R; Copigneaux C; Luo FR; Wojtowicz-Praga S; Percent I; Saleh M
Cancer Biother Radiopharm; 2010 Feb; 25(1):13-9. PubMed ID: 20187792
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
Fiveash JB; Gillespie GY; Oliver PG; Zhou T; Belenky ML; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):507-16. PubMed ID: 18474311
[TBL] [Abstract][Full Text] [Related]
10. HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo.
Pukac L; Kanakaraj P; Humphreys R; Alderson R; Bloom M; Sung C; Riccobene T; Johnson R; Fiscella M; Mahoney A; Carrell J; Boyd E; Yao XT; Zhang L; Zhong L; von Kerczek A; Shepard L; Vaughan T; Edwards B; Dobson C; Salcedo T; Albert V
Br J Cancer; 2005 Apr; 92(8):1430-41. PubMed ID: 15846298
[TBL] [Abstract][Full Text] [Related]
11. [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].
Hoffmann TK; Whiteside TL; Bier H
HNO; 2005 Mar; 53(3):285-97; quiz 298. PubMed ID: 15759168
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
15. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
[TBL] [Abstract][Full Text] [Related]
16. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
17. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
